An Open-Label Pilot Study Evaluating the Effects of Travoprost on Eyebrow Regrowth Among Patients Undergoing Chemotherapy for Cancer

Habib, Nausheen. Master of Science, Biomedical Sciences, December 2005, An Open-Label Pilot Study Evaluating the Effects of Travoprost on Eyebrow Regrowth Among Patients Undergoing Chemotherapy for Cancer. The primary objective of this study is to determine the effect of eyebrow hair growth of a twice daily application of travoprost among patients undergoing chemotherapy or those who have already completed chemotherapy. Travoprost, used clinically in the treatment of glaucoma, is topically and unilaterally applied to a total of 15 patients to induce eyebrow hair growth. This is an ongoing pilot study in which the screening, treatment and follow-up visits are scheduled on day 0, week 4, week 8, week 12, and week 14. After an eight week treatment period, 69% of the patients demonstrated increased eyebrow density. This increase in eyebrow hair is consistent with travoprost’s ability to prolong the anagen or growing phase of the hair cycle.